Crossmark

Re-evaluating the suitability of using fluoroquinolones in the treatment of infections in the context of FQ consumption and correlating changes to microorganism resistance levels in EU/EEA countries between 2016 and 2021

Crossref DOI link: https://doi.org/10.1007/s00210-023-02622-2

Published Online: 2023-07-26

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Serwacki, Piotr https://orcid.org/0000-0001-9946-7855
Gajda, Mateusz https://orcid.org/0000-0003-4383-7380
Świątek-Kwapniewska, Wioletta https://orcid.org/0000-0002-6592-4680
Wałaszek, Marta https://orcid.org/0000-0001-6712-0726
Nowak, Karolina https://orcid.org/0000-0003-3899-076X
Wójkowska-Mach, Jadwiga https://orcid.org/0000-0003-0756-1639
License Information

Text and Data Mining valid from 2023-07-26

Version of Record valid from 2023-07-26
More Information

Article History

Received: 14 March 2023

Accepted: 10 July 2023

First Online: 26 July 2023

Declarations

:

: Not applicable.

: The authors declare no competing interests.